950160.KQ
Kolon TissueGene, Inc.
KOE · Healthcare · Biotechnology · US
KRW 16,280.00
+2.52%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.47x
- Price / sales
- 278.52x
- Price / cash flow
- -76.40x
Enterprise value
- Enterprise value
- KRW 1.29T
- EV / sales
- 271.65x
- EV / EBITDA
- -10.75x
- EV / EBIT
- -53.54x
- Market cap
- KRW 1.33T
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026